Stockscreener 앱 받기
2.55
1.54%
-0.04
전일 마감가:
$2.59
열려 있는:
$2.53
하루 거래량:
41,172
Relative Volume:
1.43
시가총액:
$11.28M
수익:
$20,000
순이익/손실:
$-11.06M
주가수익비율:
-0.8963
EPS:
-2.8449
순현금흐름:
$-10.53M
1주 성능:
-3.41%
1개월 성능:
+2.82%
6개월 성능:
+22.60%
1년 성능:
+0.79%
1일 변동 폭
$2.48
$2.585
1주일 범위
$2.48
$2.65
52주 변동 폭
$1.7645
$3.01
Kiora Pharmaceuticals Inc Stock (KPRX) Company Profile
명칭
Kiora Pharmaceuticals Inc
전화
858-224-9600
주소
169 SAXONY RD., ENCINITAS
Compare KPRX vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KPRX
Kiora Pharmaceuticals Inc
|
2.55 | 11.68M | 20,000 | -11.06M | -10.53M | -2.8449 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Kiora Pharmaceuticals Inc 주식(KPRX)의 최신 뉴스
Perceptive Advisors LLC Acquires New Position in Kiora Pharmaceuticals Inc (KPRX) - GuruFocus
ADAR1 group discloses 9.9% Kiora Pharmaceuticals (KPRX) stake via shares and warrants - Stock Titan
Nantahala Capital discloses 9.99% Kiora Pharmaceuticals (KPRX) stake via 13G/A filing - Stock Titan
Kiora Pharmaceuticals (KPRX) reports 9.99% stake held by Perceptive group - Stock Titan
Form 8K Kiora Pharmaceuticals Inc For: 7 August By Investing.com - Investing.com Nigeria
Kiora Pharmaceuticals advances retinal disease trials, secures $24M funding, expects data in 2027 - Pluang
Kiora Pharmaceuticals, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Kiora Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update - TMX Newsfile
Kiora Starts Enrollment in 100-Microgram Retinitis Pigmentosa Cohort - Stock Titan
Kiora Pharmaceuticals (KPRX) Gains 2.83% as Shares Approach $2.67 ResistanceGap and Reverse - dars.gov.et
Kiora Pharmaceuticals Inc (KPRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Kiora Pharmaceuticals Market Sentiment - Benzinga España
Kiora Pharmaceuticals Inc (KPRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
KPRX|Kiora Pharmaceuticals Inc|Price:2.530|Chg%:-0.020 - TradingKey
TradingKey - TradingKey
Kiora Pharmaceuticals Inc (KPRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Kiora Pharmaceuticals Q1 2026 Earnings: EPS Beat as Pre‑Revenue Biotech Narrows Loss ExpectationsPerformance Review - dars.gov.et
Kiora Pharmaceuticals (KPRX) Edges Higher as Shares Test Key ResistanceKAMA Signal - dars.gov.et
Kiora Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:KPRX - TradingView
Kiora Pharmaceuticals Inc (KPRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Kiora Pharmaceuticals (KPRX) Slips 2.7% as Biotech Sector Faces Renewed PressureVolume Climax - dars.gov.et
Price to sales forward of Kiora Pharmaceuticals, Inc. – FWB:7EY - TradingView
Enterprise value to revenue forward of Kiora Pharmaceuticals, Inc. – FWB:7EY - TradingView
Enterprise value to revenue forward of Kiora Pharmaceuticals, Inc. – LS:A40EG5 - TradingView
Kiora Pharmaceuticals Inc. (KPRX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Enterprise value to revenue forward of Kiora Pharmaceuticals, Inc. – GETTEX:7EY - TradingView
Price to earnings forward of Kiora Pharmaceuticals, Inc. – NASDAQ:KPRX - TradingView
Price to book forward of Kiora Pharmaceuticals, Inc. – NASDAQ:KPRX - TradingView
Enterprise value to EBITDA forward of Kiora Pharmaceuticals, Inc. – NASDAQ:KPRX - TradingView
KPRXKiora Pharmaceuticals Inc Latest SEC Filings - Finviz
Form 4 Kiora Pharmaceuticals Inc For: 2 July By Investing.com - Investing.com India
Kiora (NASDAQ: KPRX) CFO uses 911 shares to cover tax obligations - Stock Titan
[Form 4] KIORA PHARMACEUTICALS INC Insider Trading Activity - Stock Titan
Kiora Pharmaceuticals (KPRX) Holds Steady Near Support as Biotech Sector WatchesRelative Volume - dars.gov.et
Kiora Pharmaceuticals to Participate in Piper Sandler Virtual Ophthalmology Symposium - TMX Newsfile
Kiora Pharmaceuticals Inc Warrant 2022-27.09.27 on Kiora Pharma A Financial Disclosures & SEC Filings - TradingView
Kiora Pharmaceuticals (KPRX) Slides Marginally as Biotech Sector Remains CautiousMonthly Profile - po-news-eg.net
Kiora Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:KPRX) - TradingView
KPRX Forecast — Price Target — Prediction for 2027 - TradingView
7EY Forecast — Price Target — Prediction for 2027 - TradingView
Why Did KPRX Stock Surge 17% Pre-Market Today? - Stocktwits
Kiora Pharmaceuticals Inc (KPRX) Institutional Confidence - TradingKey
Kiora Pharmaceuticals Inc (KPRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Analysts Are Bullish on Top Healthcare Stocks: Ascentage Pharma Group International (HK:6855), Kiora Pharmaceuticals (KPRX) - The Globe and Mail
Kiora Pharmaceuticals (KPRX) Slips Slightly as Stock Hovers Near Key Support ZoneDouble Top - dars.gov.et
KPRX SEC FilingsKIORA PHARMACEUTICALS INC 10-K, 10-Q, 8-K Forms - Stock Titan
Kiora Pharmaceuticals (KPRX) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Kiora Pharmaceuticals’ KIO-300 Shows Significant Seizure Suppression in Preclinical Epilepsy Model, Revealing Potential Beyond Ophthalmology 1 – Minichart - Minichart
Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model - TMX Newsfile
Kiora Pharmaceuticals (NASDAQ: KPRX) reports KIO-300 epilepsy model data - Stock Titan
Kiora Pharmaceuticals Inc (KPRX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Kiora Pharmaceuticals Inc (KPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.07%
자본화:
|
볼륨(24시간):